Renaissance Technologies’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Renaissance Technologies’s Portfolio MDVL Stock Details MDVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,590	Closed	-$19K	–	4244
2023 Q2	$19K	Buy	+1,590	New	+$20.3K	﹤0.01%	3779
2023 Q1	–	Sell	-1,050	Closed	-$16K	–	4501
2022 Q4	$16K	Buy	1,050 +254	+32%	+$7.31K	﹤0.01%	4002
2022 Q3	$31K	Buy	+796	New	+$45.7K	﹤0.01%	3842
2022 Q1	–	Sell	-1,080	Closed	-$76K	–	4582
2021 Q4	$76K	Buy	+1,080	New	+$116K	﹤0.01%	3729
2020 Q4	–	Sell	-366	Closed	-$301K	–	3801
2020 Q3	$301K	Buy	+366	New	+$313K	﹤0.01%	2994

Other funds holding MDVL

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies's MDVL Position: Q3 2023 in Review

Renaissance Technologies sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q3 2023, closing a stake of 1,590 shares — an estimated $19K sold.

Renaissance Technologies first reported a position in MDVL in Q3 2020 and held it in 5 quarters. The position peaked at $301K in Q3 2020. 19 funds tracked by Wall St. Rank hold MDVL as of Q3 2023.

Renaissance Technologies reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Renaissance Technologies sold 1,590 MedAvail Holdings, Inc. Common Stock shares in Q3 2023, an estimated $19K.
Renaissance Technologies first reported a position in MedAvail Holdings, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
Renaissance Technologies's MedAvail Holdings, Inc. Common Stock position peaked at $301K in Q3 2020.
19 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.